Education
About Us
Working with TipRanks
Follow Us
RxSight (RXST)
NASDAQ:RXST
Total Valuation
RxSight has a market cap or net worth of $591.43M. The enterprise value is $1.16B.
Market Cap$591.43M
Enterprise Value$1.16B
Share Statistics
RxSight has 40,620,240 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding40,620,240
Owned by Insiders4.86%
Owned by Institutions1.71%
Financial Efficiency
RxSight’s return on equity (ROE) is -0.10 and return on invested capital (ROIC) is -12.57%.
Return on Equity (ROE)-0.10
Return on Assets (ROA)-0.09
Return on Invested Capital (ROIC)-12.57%
Return on Capital Employed (ROCE)-0.13
Revenue Per Employee280.98K
Profits Per Employee0.00
Employee Count498
Asset Turnover0.44
Inventory Turnover1.86
Valuation Ratios
The current PE Ratio of RxSight is -48.67. RxSight’s PEG ratio is 0.98.
PE Ratio-48.67
PS Ratio0.00
PB Ratio4.75
Price to Fair Value4.75
Price to FCF-59.69
Price to Operating Cash Flow-78.85
PEG Ratio0.98
Income Statement
In the last 12 months, RxSight had revenue of 139.93M and earned -27.45M in profits. Earnings per share was -0.71.
Revenue139.93M
Gross Profit98.94M
Operating Income-36.86M
Pretax Income-27.41M
Net Income-27.45M
EBITDA-23.76M
Earnings Per Share (EPS)-0.71
Cash Flow
In the last 12 months, operating cash flow was -17.03M and capital expenditures -5.44M, giving a free cash flow of -22.47M billion.
Operating Cash Flow-17.03M
Free Cash Flow-22.47M
Free Cash Flow per Share-0.55
Dividends & Yields
RxSight pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.53
52-Week Price Change-70.77%
50-Day Moving Average22.75
200-Day Moving Average39.30
Relative Strength Index (RSI)27.96
Average Volume (3m)1.04M
Important Dates
RxSight upcoming earnings date is May 7, 2025, TBA Not Confirmed.
Last Earnings DateFeb 25, 2025
Next Earnings DateMay 7, 2025
Ex-Dividend Date―
Financial Position
RxSight as a current ratio of 11.36, with Debt / Equity ratio of 4.37%
Current Ratio11.36
Quick Ratio10.50
Debt to Market Cap<0.01
Net Debt to EBITDA0.19
Interest Coverage Ratio-1.76K
Taxes
In the past 12 months, RxSight has paid 50.00K in taxes.
Income Tax50.00K
Effective Tax Rate>-0.01
Enterprise Valuation
RxSight EV to EBITDA ratio is -56.05, with an EV/FCF ratio of -59.50.
EV to Sales9.52
EV to EBITDA-56.05
EV to Free Cash Flow-59.50
EV to Operating Cash Flow-78.59
Balance Sheet
RxSight has $237.22M in cash and marketable securities with $12.30M in debt, giving a net cash position of -$224.93M billion.
Cash & Marketable Securities$237.22M
Total Debt$12.30M
Net Cash-$224.93M
Net Cash Per Share-$5.54
Tangible Book Value Per Share$7.24
Margins
Gross margin is 65.95%, with operating margin of -26.34%, and net profit margin of -19.62%.
Gross Margin65.95%
Operating Margin-26.34%
Pretax Margin-19.59%
Net Profit Margin-19.62%
EBITDA Margin-16.98%
EBIT Margin-19.57%
Analyst Forecast
The average price target for RxSight is $26.00, which is 11.43% higher than the current price. The consensus rating is Hold
Price Target$26.00
Price Target Upside78.57% Upside
Analyst ConsensusHold
Analyst Count10
Revenue Growth Forecast57.08%
EPS Growth Forecast49.93%